Skip to main content

Advertisement

Log in

Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To compare hepatobiliary phase (HBP) images obtained 10 and 20 min after Gd-EOB-DTPA-enhanced MRI for liver function assessment in clinic on 3.0 T MR imaging.

Methods

103 patients were separated into four groups: 38 patients for the normal liver function (NLF) group, 33 patients for the liver cirrhosis with Child–Pugh A (LCA) group, 21 patients for the liver cirrhosis with Child–Pugh B group, and 11 patients for a liver cirrhosis with Child–Pugh C group. T1 relaxation times (T1rt) were measured on T1 mapping and reduction rates of T1rt (rrT1rt) were calculated. HBP images were obtained at the 10- and 20-min mark after Gd-EOB-DTPA enhancement.

Results

T1rt on pre-enhancement imaging showed no significant difference (p > 0.05) among all four groups. T1rt for both the 10-min HBP and the 20-min HBP showed a significant difference (p < 0.05) among all groups, but showed no significant difference (p > 0.05) between the NLF group and the LCA group. T1rt and rrT1rt showed no significant difference (p > 0.05) between 10-min HBP and 20-min HBP among all groups. The ROC analysis on 10-min HBP and 20-min HBP showed a lower diagnostic performance between NLF group and LCA group (AUC from 0.532 to 0.582), but high diagnostic performance (AUC from 0.788 to 1.000) among others group.

Conclusions

In comparing 10-min HBP and 20-min HBP T1 mapping after Gd-EOB-DTPA enhancement, our results suggest that 10-min HBP T1 mapping is a feasible option for quantitatively assessing liver function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

AUC:

Area under the curve

CNR:

Contrast-to-noise ratio

Gd-EOB-DTPA:

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid

HBP:

Hepatobiliary phase

MRI:

Magnetic resonance imaging

MELD:

Model for end-stage liver disease

ROC:

Receiver operating characteristic

ROI:

Region of interest

rrT1rt:

Reduction rate of T1 relaxation time

SI:

Signal intensity

SNR:

Signal-to-noise ratio

T1rt:

T1 relaxation time

References

  1. Kim T, Murakami T, Hasuike Y, et al. (1997) Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 7(4):683–688

    Article  CAS  PubMed  Google Scholar 

  2. Shimizu J, Dono K, Gotoh M, et al. (1999) Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci 44(7):1330–1337

    Article  CAS  PubMed  Google Scholar 

  3. Hamm B, Staks T, Muhler A, et al. (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195(3):785–792. doi:10.1148/radiology.195.3.7754011

    Article  CAS  PubMed  Google Scholar 

  4. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183(1):59–64. doi:10.1148/radiology.183.1.1549695

    Article  CAS  PubMed  Google Scholar 

  5. Haimerl M, Schlabeck M, Verloh N, et al. (2016) Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry. Eur Radiol 26(4):1125–1133. doi:10.1007/s00330-015-3919-5

    Article  PubMed  Google Scholar 

  6. Verloh N, Utpatel K, Haimerl M, et al. (2015) Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: a histopathologic correlation. Sci Rep 5:15408. doi:10.1038/srep15408

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Durand F, Valla D (2005) Assessment of the prognosis of cirrhosis: child–pugh versus MELD. J Hepatol 42(Suppl (1)):S100–107. doi:10.1016/j.jhep.2004.11.015

    Article  PubMed  Google Scholar 

  8. Takamura T, Motosugi U, Ichikawa S, et al. (2016) Usefulness of MR elastography for detecting clinical progression of cirrhosis from child–pugh class A to B in patients with type C viral hepatitis. J Magn Reson Imaging . doi:10.1002/jmri.25182

    PubMed  Google Scholar 

  9. Horsthuis K, Nederveen AJ, de Feiter MW, et al. (2009) Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn’s disease: a feasibility study. J Magn Reson Imaging 29(2):488–493. doi:10.1002/jmri.21535

    Article  PubMed  Google Scholar 

  10. Shah NJ, Neeb H, Zaitsev M, et al. (2003) Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 38(5):1219–1226. doi:10.1053/jhep.2003.50477

    Article  PubMed  Google Scholar 

  11. Yoshimura N, Saito K, Saguchi T, et al. (2013) Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI. Magn Reson Imaging 31(1):23–27. doi:10.1016/j.mri.2012.06.026

    Article  CAS  PubMed  Google Scholar 

  12. Bae KE, Kim SY, Lee SS, et al. (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30(6):617–622. doi:10.1159/000343092

    Article  PubMed  Google Scholar 

  13. Ding Y, Rao SX, Meng T, et al. (2014) Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease. Eur Radiol 24(4):959–966. doi:10.1007/s00330-014-3096-y

    Article  PubMed  Google Scholar 

  14. Katsube T, Okada M, Kumano S, et al. (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Investig Radiol 46(4):277–283. doi:10.1097/RLI.0b013e318200f67d

    Article  Google Scholar 

  15. Haimerl M, Verloh N, Fellner C, et al. (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621. doi:10.1038/srep05621

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ding Y, Rao SX, Chen C, Li R, Zeng MS (2015) Assessing liver function in patients with HBV-related HCC: a comparison of T(1) mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI. Eur Radiol 25(5):1392–1398. doi:10.1007/s00330-014-3542-x

    Article  PubMed  Google Scholar 

  17. Yoon JH, Lee JM, Paek M, Han JK, Choi BI (2016) Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol 26(6):1775–1782. doi:10.1007/s00330-015-3994-7

    Article  PubMed  Google Scholar 

  18. Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57(2):421–429. doi:10.1016/j.jhep.2012.01.031

    Article  PubMed  Google Scholar 

  19. van Montfoort JE, Stieger B, Meijer DK, et al. (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290(1):153–157

    PubMed  Google Scholar 

  20. Planchamp C, Montet X, Frossard JL, et al. (2005) Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers. Investig Radiol 40(4):187–194

    Article  CAS  Google Scholar 

  21. Reimer P, Rummeny EJ, Shamsi K, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199(1):177–183. doi:10.1148/radiology.199.1.8633143

    Article  CAS  PubMed  Google Scholar 

  22. Tamada T, Ito K, Higaki A, et al. (2011) Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol 80(3):e311–316. doi:10.1016/j.ejrad.2011.01.020

    Article  PubMed  Google Scholar 

  23. Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K (2011) Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 21(11):2336–2343. doi:10.1007/s00330-011-2197-0

    Article  PubMed  Google Scholar 

  24. Ramalho M, Heredia V, Tsurusaki M, Altun E, Semelka RC (2009) Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 29(4):869–879. doi:10.1002/jmri.21719

    Article  PubMed  Google Scholar 

  25. Tsurusaki M, Semelka RC, Zapparoli M, et al. (2009) Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol 72(2):314–320. doi:10.1016/j.ejrad.2008.07.027

    Article  PubMed  Google Scholar 

  26. Kamimura K, Fukukura Y, Yoneyama T, et al. (2014) Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. J Magn Reson Imaging 40(4):884–889. doi:10.1002/jmri.24443

    Article  PubMed  Google Scholar 

  27. Haimerl M, Verloh N, Zeman F, et al. (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PloS ONE 8(12):e85658. doi:10.1371/journal.pone.0085658

    Article  PubMed  PubMed Central  Google Scholar 

  28. Cassinotto C, Feldis M, Vergniol J, et al. (2015) MR relaxometry in chronic liver diseases: comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 84(8):1459–1465. doi:10.1016/j.ejrad.2015.05.019

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Thanks for Dr. Kyongtae Bae and Dr. Cheng Tao from University of Pittsburgh Medical Centre for giving comments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhong-Kui Huang.

Ethics declarations

Funding

This study was funded by the National Natural Science Foundation of China (Grant No. 81260214), the State Key Program of Health Care of Guangxi (Grant No. 2012080), and the Innovation Project of Guangxi Graduate Education (Grant No. YCBZ2015029).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, ZP., Long, LL., Qiu, WJ. et al. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic. Abdom Radiol 42, 2272–2278 (2017). https://doi.org/10.1007/s00261-017-1143-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-017-1143-2

Keywords

Navigation